Patent · US Active

Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use

US9365524B2 · kind B2 · utility

20Cited by

10References

36Claims

0Family size

Assignee

Signal Pharmaceuticals, LLC · US

Inventors

Hon-Wah Man · Princeton, US
Jean Xu · Hackettstown, US
Marie Georges Beauchamps · Dover, US
Mohit Atul Kothare · Bound Brook Junction, US
Nanfei Zou · Fanwood, US
Ying Li · Millburn, US
Lianfeng Huang · Jalan Pedongkelan, US
Daozhong Zou · Bound Brook, US

Key dates

Filing date	Jan 29, 2015
Grant date	Jun 14, 2016
Priority date	—
Expiry date	Jan 29, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D239/48
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are formulations, processes, solid forms and methods of use relating to 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.